Primary Site >> Liver Cancer
Gene >> STAT4
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. PMID: 15688366 |
Ref: Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. PMID: 23242368 Ref: A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma. PMID: 23748017 Ref: Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population. PMID: 24204805 |
Ref: Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis. PMID: 25365208 |
Ref: STAT4 gene polymorphism and risk of chronic hepatitis B-induced hepatocellular carcinoma. PMID: 25178516 Ref: Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. PMID: 25370454 Ref: Replication the association of 2q32.2-q32.3 and 14q32.11 with hepatocellular carcinoma. PMID: 25665738 Ref: Signal transducer and activator of transcription 4 in liver diseases. PMID: 25798064 Ref: STAT4 genetic polymorphisms association with spontaneous clearance of hepatitis B virus infection. PMID: 25829184 Ref: Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. PMID: 25913043 Ref: Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis. PMID: 26538132 |
Ref: Host genetic variants influencing the clinical course of hepatitis B virus infection. PMID: 26255971 Ref: Genetic variation in STAT4 predicts response to interferon-alpha therapy for hepatitis B e antigen-positive chronic hepatitis B. PMID: 26704347 |
Ref: Meta-analysis reveals an association between signal transducer and activator of transcription-4 polymorphism and hepatocellular carcinoma risk. PMID: 27126090 Ref: In silico analysis of fragile histidine triad involved in regression of carcinoma. PMID: 28420927 |
Ref: TLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expression. PMID: 29793131 Ref: A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. PMID: 29963713 Ref: Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma. PMID: 30073017 Ref: PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases. PMID: 30289982 Ref: Systematic Review and Meta-Analysis on the Association between Polymorphisms in Genes of IL-12 Signaling Pathway and Hepatocellular Carcinoma Risk. PMID: 30310516 |